# Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure

> **NCT02607319** · PHASE4 · COMPLETED · sponsor: **American University of Beirut Medical Center** · enrollment: 165 (actual)

## Conditions studied

- Sterility

## Interventions

- **DRUG:** Bemiparin sodium

## Key facts

- **NCT ID:** NCT02607319
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607319, "Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02607319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*